Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men

mBio

Volumn 4, Issue 6, 2013, Pages

  Hobbs, Marcia M ^a   Anderson, James E ^a   Balthazar, Jacqueline T ^b,c   Kandler, Justin L ^b,c   Carlson, Russell W ^d   Ganguly, Jhuma ^d,e   Begum, Afrin A ^f   Duncan, Joseph A ^a   Lin, Jessica T ^a   Sparling, P Frederick ^a   Jerse, Ann E ^f   Shafer, William M ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e Uniformed Services University of the Health Sciences   (United States)

^f INDIAN INSTITUTE OF ENGINEERING SCIENCE AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID A; PHOSPHOETHANOLAMINE; ETHANOLAMINE DERIVATIVE; ETHANOLAMINE PHOSPHOTRANSFERASE; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONTROLLED STUDY; ENZYME SYNTHESIS; EXPERIMENTAL GENITAL TRACT INFECTION; EXPERIMENTAL INFECTION; FEMALE; FEMALE GENITAL SYSTEM; GONORRHEA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INOCULATION; MALE; MALE GENITAL SYSTEM; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; ANIMAL; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; GENE INACTIVATION; GENETICS; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOUSE; NORMAL HUMAN; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; ETHANOLAMINEPHOSPHOTRANSFERASE; ETHANOLAMINES; FEMALE; GENE KNOCKOUT TECHNIQUES; GONORRHEA; HEALTHY VOLUNTEERS; HUMANS; LIPID A; MALE; MICE; MICROBIAL VIABILITY; NEISSERIA GONORRHOEAE; VIRULENCE; VIRULENCE FACTORS;

EID: 84891599758     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00892-13     Document Type: Article

References (20)

1. World Health Organization. 2012. Global incidence and prevalence of selected curable sexually transmitted infections-2008. WHO, Geneva, Switzerland.
2. Unemo M, Shafer WM. 2011. Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann. N. Y. Acad. Sci. 1230:E19-E28. doi:10.1111/j.1749-6632.2011.06215.x.
3. Lewis DA. 2010. The gonococcus fights back: is this time a knock out? Sex. Transm. Infect. 86:415-421.
4. Shafer WM, Datta A, Kolli VS, Rahman MM, Balthazar JT, Martin LE, Veal WL, Stephens DS, Carlson R. 2002. Phase variable changes in genes lgtA and lgtC within the lgtABCDE operon of Neisseria gonorrhoeae can modulate gonococcal susceptibility to normal human serum. J. Endotoxin Res. 8:47-58.
5. Lewis LA, Choudhury B, Balthazar JT, Martin LE, Ram S, Rice PA, Stephens DS, Carlson R, Shafer WM. 2009. Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect. Immun. 77:1112-1120.
6. Lewis LA, Shafer WM, Dutta Ray T, Ram S, Rice PA. 2013. Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect. Immun. 81:33-42.
7. John CM, Liu M, Jarvis GA. 2009. Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes. J. Biol. Chem. 284: 21515-21525.
8. Liu M, John CM, Jarvis GA. 2010. Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88and TRIF-dependent TLR4-MD-2 signaling pathways. J. Immunol. 185:6974-6984.
9. Balthazar JT, Gusa A, Martin LE, Chouhury B, Carlson R, Shafer WM. 2011. Lipooligosaccharide structure is an important determinant in the resistance of Neisseria gonorrhoeae to antimicrobial agents of innate host defense. Front. Microbiol. 2:30.
10. Hobbs MM, Sparling PF, Cohen MS, Shafer WM, Deal CD, Jerse AE. 2011. Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC. Front. Microbiol. 2:123.
11. Cohen MS, Cannon JG, Jerse AE, Charniga LM, Isbey SF, Whicker LG. 1994. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169:532-537.
12. Johnston DM, Cannon JG. 1999. Construction of mutant strains of Neisseria gonorrhoeae lacking new antibiotic resistance markers using a two gene cassette with positive and negative selection. Gene 236: 179-184.
13. Song W, Condron S, Mocca BT, Veit SJ, Hill D, Abbas A, Jerse AE. August 2008. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradioltreated mice. Vaccine 26:5741-5751.
14. Seifert HS, Wright CJ, Jerse AE, Cohen MS, Cannon JG. 1994. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Invest. 93:2744-2749.
15. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, Zahos KM, Apicella MA. 1991. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:1601-1605.
16. Feinen B, Jerse AE, Gaffen SL, Russell MW. 2010. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 3:312-321.
17. Jerse AE, Wu H, Packiam M, Vonck RA, Begum AA, Garvin LE. 2011. Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections. Front. Microbiol. 2:107.
18. Packiam M, Veit SJ, Anderson DJ, Ingalls RR, Jerse AE. 2010. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78: 433-440.
19. Packiam M, Begum A, Sempowski G, Carlson R, Shafer W, Jerse A. 2012. Phosphoethanolamine modification of gonococcal lipid A confers an in vivo survival advantage and modulates induction of proinflammatory cytokines by differential binding to cationic antimicrobial peptides, poster P 219, p 365. Prog. XVIIIth Int. Pathog. Neisseria Conf. (IPNC). University of Würzburg, Wurzburg, Germany. http://neisseria.org/ipnc/2012/IPNC_2012_abstracts.pdf.
20. John CM, Liu M, Phillips NJ, Yang Z, Funk CR, Zimmerman LI, Griffiss JM, Stein DC, Jarvis GA. 2012. Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals. Infect. Immun. 80:4014-4026.